Home/ Stocks/ CDT

CDT Equity Inc. Common Stock

CDT XNAS

$0.49 +0.01 (+2.92%) ▲ 15-min delayed

Open

$0.50

High

$0.52

Low

$0.48

Volume

64.9K

Market Cap

$2.15M

About CDT Equity Inc. Common Stock

CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. The company has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The group is committed to creating shareholder value through licensing, strategic M&A, and positioning the company as a platform for transformative innovation.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 6 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$0	$-7,118,000	$-13.16
Q2 2025	$0	$-6,028,000	$-5.46
Q1 2025	$0	$-5,146,000	$-1.32
FY 2024	$0	$-17,802,000	$-20.53

Earnings & Analyst Ratings

Next Earnings: Mon, May 11, 2026

Calendar →

Related Market News

No specific coverage for CDT yet. Check out our latest market news or earnings calendar.

Get CDT Alerts

Stay ahead with breaking news, price alerts, and expert analysis on CDT Equity Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.